Cetrilev Neo film-coated tablets 5 mg 100 pcs.

Active ingredient: levocetirizine.

One tablet contains excipients: microcrystalline cellulose, colloidal silicon dioxide, lactose, magnesium stearate, hypromellose E 464, titanium dioxide E 171, polysorbate, macrogol 400.

Hypersensitivity to levocetirizine, other piperazine derivatives, as well as to other components of the drug.

Severe form of chronic renal failure.

Hereditary galactose intolerance, lactase enzyme deficiency or glucose-galactose malabsorption.

Pregnancy, breastfeeding period, children under 6 years of age.

The drug is prescribed to adults and children over 6 years of age orally at a dose of 5 mg once a day.

Take the tablet with food or on an empty stomach, without chewing, with a small amount of water.

For children

The drug in tablet form should not be used in children under 6 years of age, as this dosage form does not allow for the necessary correction of the dosage regimen.

For this category of patients, the use of levocetirizine in a dosage form suitable for use in pediatrics is recommended.

Pregnant

It is contraindicated to use during pregnancy.

The drug penetrates into breast milk, therefore, if necessary, use of the drug should be discontinued.

Drivers

You should refrain from driving or operating machinery during treatment.

May have signs of intoxication in the form of drowsiness.

In children, overdose is accompanied by anxiety and increased irritability.

If symptoms of overdose appear, especially in children, the drug should be discontinued, gastric lavage should be performed, and activated charcoal should be administered.

The following types of violations occur:

• From the nervous system: drowsiness, headache, fatigue, weakness, asthenia, convulsions, paresthesias, dizziness, fainting, tremor, dysgeusia.
• Psychiatric: sleep disturbances, agitation, hallucinations, depression, aggression, insomnia, suicidal thoughts.
• From the organs of hearing and balance: vertigo.
• Hepatobiliary disorders: hepatitis.
• Renal and urinary disorders: dysuria, urinary retention.
• Immune system disorders: hypersensitivity, including anaphylaxis, angioedema.
• Respiratory, thoracic and mediastinal disorders: dyspnea.
• On the part of the digestive system: diarrhea, vomiting, constipation, dry mouth, nausea, abdominal pain.
• Skin and subcutaneous tissue disorders: angioedema, persistent drug eruptions, pruritus, rash, urticaria.
• Musculoskeletal, connective tissue and bone disorders: muscle pain.

Concomitant use with pseudoephedrine, cimetidine, ketoconazole, erythromycin, azithromycin, glipizide, or diazepam does not cause clinically significant adverse interactions.

Co-administration with theophylline reduces the total clearance of levocetirizine by 16%.

When used in therapeutic doses, no enhancement of the effect of sedatives was observed, but it is advisable to refrain from using sedatives during therapy.

Shelf life 3 years.

Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.